Senti BiosciencesSNTI
13F holders, Q3 2025 (September 30)15holders +1
5new positions
4sold out
1famous investor
$1.41avg. 13F price*
At the end of Q3 2025, 15 institutions reported holding Senti Biosciences Inc. (SNTI) in their 13F filings, up 1 from Q2 2025. 5 opened new positions and 4 sold out. The largest holders were NEA Management Company, LLC ($5.3M), Nantahala Capital Management, LLC ($1.3M) and Vanguard Group Inc. ($869K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Senti Biosciences Inc.
- CUSIP
- 81726A209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $200K |
| Exits | 4 | $2.7M |
All 13F filers, Q2 2025 → Q3 2025: 403,414 shares bought and 1,278,681 shares sold, net −875,267 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 15 holders
| NEA Management Company, LLC | 0.29% | No change | 3,775,615 | $5.3M |
| Nantahala Capital Management, LLC | 0.08% | No change | 888,000 | $1.3M |
| Vanguard Group Inc. | 0.00% | Add +70.7% | 616,073 | $869K |
| Geode Capital Management, LLC | 0.00% | Add +3.8% | 152,838 | $216K |
| Citadel Advisors | 0.00% | New | 82,753 | $117K |
| XTX Topco Ltd | 0.00% | New | 26,567 | $37K |
| BlackRock, Inc. | 0.00% | Add +2.4% | 22,604 | $32K |
| Northern Trust Corp. | 0.00% | New | 16,310 | $23K |
| Two Sigma Investments, LP | 0.00% | New | 15,968 | $23K |
| State Street Corp. | 0.00% | No change | 10,010 | $14K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +54.3% | 1,730 | $2K |
| Bank of America Corp. | 0.00% | Reduce -19.2% | 450 | $634 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -0.6% | 336 | $474 |
| Morgan Stanley | 0.00% | No change | 160 | $226 |
| Citigroup Inc. | 0.00% | New | 1 | $1 |
"% of holder's portfolio" is SNTI's weight in each manager's 13F, not the share of Senti Biosciences Inc. the manager owns.